AISTHESIS MEDICAL LIMITED

🌿Early-stageactive

15475459 · ltd · incorporated 2024-02-09

Investment thesis

Growth-phase business — story-led; valuation sensitive to momentum.

Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.

Why risky: Price often leads fundamentals; dependency on founder often high.

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Dec 2025

Net worth

£536.3k

book net assets

Opportunity

75/100

Strong

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Research and experimental development on biotechnology

Sector: Professional, scientific & technical

Investor take

Pursue

Strong opportunity: asset-holding vehicle with strong profile and acceptable with review structure.

Opportunity 75/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (70/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

1 year of iXBRL accounts extracted (no YoY comparison) + narrative notes parsed

Lenders & charges

Confirmed no charges registered

Directors & officers

4 officers (4 active, 4 linked, 4 with DOB)

Ownership & PSC

3 active PSC(s) of 3 total, 3 with control declared

Director network

Network not yet resolved

Filing history

35 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

75/100Strong

PassWatchWorth a lookStrongExceptional

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality

Adequate — check latest filings for context.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared

Positive net assets

Net assets £536,324

Key financials

1 year extracted from filed iXBRL accounts

Cash

£541k

Net Worth

£536k

Current Assets

£544k

Current Liabilities

—

Financials

Extracted from Companies House accounts · accounting standard unknown

Metric	2025-12-31
Total assets	£536.3k
Current assets	£544.0k
Cash	£541.2k
Debtors	£2.8k
Net assets	£536.3k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

3 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filings

Last 90 days

filing

• 1 accounts

Last 180 days

filings

• 1 accounts
• 1 confirmation-statement
• 1 officers

Counts from Companies House filing history.

Corporate timeline (28 events)Click to expand

2026-04-01
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2026-02-12
📄
appoint-person-director-company-with-name-date
officers · AP01
2026-02-03
📄
capital-allotment-shares
capital · SH01
2026-01-26
➕
MILLER, Iain appointed
director
2025-11-18
📄
capital-allotment-shares
capital · SH01
2025-11-10
📄
change-person-director-company-with-change-date
officers · CH01
2025-11-10
📄
change-person-director-company-with-change-date
officers · CH01
2025-11-10
📄
change-person-director-company-with-change-date
officers · CH01
2025-11-10
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-11-10
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-11-10
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-11-09
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-11-09
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-11-09
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-09-24
📄
legacy
miscellaneous · RP01SH01
2025-09-19
📄
capital-allotment-shares
capital · SH01
2025-05-21
📍
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-03-31
📄
capital-allotment-shares
capital · SH01
2025-03-28
📄
capital-allotment-shares
capital · SH01
2025-03-28
📄
capital-allotment-shares
capital · SH01
2025-03-27
📄
memorandum-articles
incorporation · MA
2025-03-27
📄
resolution
resolution · RESOLUTIONS
2025-03-07
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-03-07
📄
change-person-director-company-with-change-date
officers · CH01
2024-02-09
🏢
Company incorporated
As AISTHESIS MEDICAL LIMITED
2024-02-09
➕
DIMAKOPOULOS, Vasileios appointed
director
2024-02-09
➕
GKOUZIONIS, Ioannis appointed
director
2024-02-09
➕
LILIOPOULOS, Sotirios appointed
director

Owner dependency

53/100

Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS

-4 active directors: Broader management team in place — suggests transferable governance.
+Senior director age: Director aged approximately 62 — approaching natural succession window.
+Young company: Only 2.4 years old — management layer unlikely to be developed.

Succession & seller-readiness

40/100

Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS

secondaryFounder aged 58+: Senior director is approximately 62. Early succession window.

Red flags

clean

No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

3 active beneficial owners

Name	Shares	Voting rights	Nature of control	Notified
Ioannis Gkouzionis Individual · Greek · DOB 12/1994 · age 32	—	—	sig. influencesignificant influence	09/02/2024
Vasileios Dimakopoulos Individual · Greek · DOB 08/1994 · age 32	—	—	sig. influencesignificant influence	09/02/2024
Sotirios Liliopoulos Individual · Greek · DOB 11/1994 · age 32	—	—	sig. influencesignificant influence	09/02/2024

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Professional services · SE postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
A J LYTHGOE LIMITED→ 11906033 · est 2019 · no financials extracted	—	—	—	—	7y	—	—
AIGA LAB LIMITED→ 11338160 · est 2018 · no financials extracted	—	—	—	—	7y	—	—
AIM ACCOUNTANCY SERVICES LIMITED→ 05041555 · est 2004 · no financials extracted	—	—	—	—	22y	—	—
AIMON CONSULTANCY LIMITED→ 08576870 · est 2013 · no financials extracted	—	—	—	—	12y	—	—
AIPLIFY RESEARCH LTD→ 15458101 · est 2024 · no financials extracted	—	—	—	—	2y	—	—
AIR SWFT LIMITED→ 16605515 · est 2025 · no financials extracted	—	—	—	—	—	—	—
AIRC.DESIGN LTD→ 12888379 · est 2020 · no financials extracted	—	—	—	—	5y	—	—
AIREX TECHNOLOGIES LTD→ 10017714 · est 2016 · no financials extracted	—	—	—	—	10y	—	—
AIRSOUND LTD→ 15919824 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
AISHA SANUSI LTD→ 15728382 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
AIVIKO LTD→ 07991702 · est 2012 · no financials extracted	—	—	—	—	14y	—	—
AJ CARE LIMITED→ 14086468 · est 2022 · no financials extracted	—	—	—	—	3y	—	—

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2024-02-09

Jurisdictionengland-wales

Primary SIC72110 — Research and experimental development on biotechnology

Registered office

1 Royal Street

London

SE1 7LL

England

Filing status

Accounts

Next due: 2027-09-30

Last made up to: 2025-12-31

Confirmation statement

Next due: 2027-02-22

Last: 2026-02-08

Officers (4 active · 0 resigned)

DIMAKOPOULOS, Vasileios→

director · ~32y · appointed 2024-02-09

View their other companies + combined net worth →

Active

GKOUZIONIS, Ioannis→

director · ~32y · appointed 2024-02-09

View their other companies + combined net worth →

Active

LILIOPOULOS, Sotirios→

director · ~32y · appointed 2024-02-09

View their other companies + combined net worth →

Active

MILLER, Iain→

director · ~62y · appointed 2026-01-26

View their other companies + combined net worth →

Active

Click a director name to see their full track record across all companies.

Recent filings (35 total)

accounts-with-accounts-type-total-exemption-full

accounts · AA

2026-04-01

confirmation-statement-with-updates

confirmation-statement · CS01

2026-02-12

appoint-person-director-company-with-name-date

officers · AP01

2026-02-12

capital-allotment-shares

capital · SH01

2026-02-03

capital-allotment-shares

capital · SH01

2025-11-18

change-person-director-company-with-change-date

officers · CH01

2025-11-10

change-person-director-company-with-change-date

officers · CH01

2025-11-10

change-person-director-company-with-change-date

officers · CH01

2025-11-10

change-to-a-person-with-significant-control